Tofacitinib Approved: Now How Do We Use It?
Dr. Jonathan Kay discusses the potential role of the recently approved oral kinase inhibitor tofacitinib for rheumatoid arthritis.
Source: Medscape Rheumatology Podcast - Category: Rheumatology Authors: Medscape Source Type: podcasts